Successful treatment of children with juvenile systemic sclerosis using mycophenolate mofetil after methylprednisolone pulse therapy: A 3-year follow-up

Int J Rheum Dis. 2022 Jan;25(1):95-96. doi: 10.1111/1756-185X.14260. Epub 2021 Dec 5.

Authors

Akinori Furusawa¹, Hiroyuki Wakiguchi¹, Fumiko Okazaki¹, Yuno Korenaga¹, Yoshihiro Azuma¹, Hiroki Yasudo¹, Shunji Hasegawa¹

Affiliation

¹ Department of Pediatrics, Yamaguchi University Graduate School of Medicine, Ube, Japan.

PMID: 34866347
DOI: 10.1111/1756-185X.14260

No abstract available

Keywords: SSc; anti-Scl-70 antibody; diffuse scleroderma skin disease; mRSS; modified Rodnan total skin thickness score; prednisolone.

Publication types

Case Reports
Letter

MeSH terms

Adolescent
Anti-Inflammatory Agents
Child, Preschool
Female
Follow-Up Studies
Humans
Male
Methylprednisolone / administration & dosage*
Mycophenolic Acid / administration & dosage*
Scleroderma, Localized / diagnosis
Scleroderma, Localized / drug therapy*
Scleroderma, Systemic / diagnosis
Scleroderma, Systemic / drug therapy*
Treatment Outcome

Substances

Anti-Inflammatory Agents
Mycophenolic Acid
Methylprednisolone

Supplementary concepts

Juvenile-onset scleroderma